Treatment of ischemic disease using thrombopoietin

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/19 (2006.01) A61P 9/10 (2006.01) A61P 41/00 (2006.01)

Patent

CA 2636426

A therapeutic or prophylactic treatment method of ischemia, such as due to myocardial infarction, by administering thrombopoietin, alone or in combination with other drugs, to a patient suffering from or at risk of cardiac injury, such as myocardial ischemia. The thrombopoietin is administered in a concentration such that the subject's platelet count or production of platelets is not significantly affected.

L'invention concerne un traitement thérapeutique ou prophylactique de l'ischémie, due par exemple à un infarctus du myocarde, qui consiste à administrer de la thrombopoïétine, seule ou en combinaison avec d'autres médicaments, à un patient atteint d'une lésion cardiaque ou présentant un risque de lésion cardiaque telle que l'ischémie myocardique. La thrombopoïétine est administrée à une concentration n'influençant pas notablement le nombre ou la production de plaquettes du sujet.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Treatment of ischemic disease using thrombopoietin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of ischemic disease using thrombopoietin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of ischemic disease using thrombopoietin will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1640129

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.